PATENT CLAIM ANALYSIS

Application Number: 15874947
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "326000"]

Abstract:
The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease.

Claim (Index 13):
A method of treating the progression of mild cognitive impairment to Alzheimer's disease in a patient, comprising administering to a patient in need of such treatment an effective amount of a compound of  claim 3 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15045305', '13296384', '13501587', '13883788', '11926409']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7851814768224562
- 35 USC 102 Novelty (BERT): 0.498966837950385
- Combined Prediction Score: 0.7565600129352491
- Mean Citation Score: 264.797334
- Max Citation Score: 272.23907
- Similarity Product: 221.3200500813645

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test